‘Pharma Bro’ Shkreli to Be Sentenced for Defrauding Investors

Former pharmaceutical executive Martin Shkreli pauses while speaking to the press after the jury issued a verdict in his case at the U.S. District Court for the Eastern District of New York in the Brooklyn borough of New York City on Aug. 4, 2017. Drew Angerer/Getty Images

NEW YORK—Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was found guilty of defrauding investors, is scheduled to be sentenced on Friday March 9.

Shkreli, 34, is expected to appear before U.S. District Judge Kiyo Matsumoto in federal court in Brooklyn, New York. His lawyers have asked the judge to impose a sentence of 12 to 18 months, while prosecutors have sought at least 15 years.